Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) COO Jonathan Yen-Wen Yu sold 300 shares of the company’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $72.50, for a total value of $21,750.00. Following the completion of the transaction, the chief operating officer owned 54,324 shares […]

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) CFO Tiago Girao sold 10,000 shares of the stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $38.46, for a total value of $384,600.00. Following the completion of the transaction, the chief financial officer owned 247,596 shares in […]

ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) Director Barry Simon sold 25,000 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $7.88, for a total value of $197,000.00. Following the completion of the sale, the director directly owned 2,802,788 shares in the company, […]

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) CEO John Quisel sold 34,000 shares of the business’s stock in a transaction that occurred on Thursday, June 18th. The stock was sold at an average price of $70.21, for a total transaction of $2,387,140.00. Following the completion of the transaction, the chief executive officer directly owned […]

Immunome, Inc. (NASDAQ:IMNM – Get Free Report) CFO Max Rosett sold 60,000 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $18.23, for a total value of $1,093,800.00. Following the transaction, the chief financial officer directly owned 54,037 shares of the […]